Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microvision (MVIS) -- Ignore unavailable to you. Want to Upgrade?

To: emil who wrote (810)	1/8/1998 2:30:00 PM
From: Jan Johnsen	Read Replies (1) \| Respond to of 7720

I share your frustration regarding the company's low stock valuation. Clearly we have "killer technology", a company with a great business plan and solid management. I have discussed the company with several of my work colleagues and they too agree that the company has a great future. The only concern expressed, by only one or two - out of ten total, is the perceived hang-up of any health risk in using the VRD. It was explained that the light was 10,000 to 100,000 times less than considered safe by ANSI. However, this still failed to convince them. It's my opinion, the company needs to address the perception that the light can be harmful to the eyes. A suggestion would be to publish a study by a recognized health organization - to validate what we already know - that the VRD is absolutely safe to use. Or even some PR pointing out that if the VRD can help a blind person with cataracts regain their vision, then how can it possibly be harmful? Perhaps with this issue put to rest, the company would gain wider public acceptance and the stock price will continue it's upward trend.